Rotarix News (1 article)
Rotarix™ significantly reduced severe rotavirus gastroenteritis in African babies during their first year of life
The New England Journal of Medicine (NEJM) published the first study demonstrating that Rotarix™, GlaxoSmithKline’s rotavirus vaccine, significantly prevented severe rotavirus gastroenteritis during the first year of life in African babies. In the study Rotarix prevented the disease in 61.2%...
Published on 28 January 2010, 04:34
We have launched our peer- reviewed, Open-access journal: Insciences Journal